Market Research Logo

Immunotherapy Drugs - Global Market Outlook (2016-2022)

Immunotherapy Drugs - Global Market Outlook (2016-2022)

According to Stratistics MRC, the Global Immunotherapy Drugs market is accounted for $38.26 billion in 2015 and is expected to reach $97.47 billion by 2022 growing at a CAGR of 14.3%. In present scenario people are exposed to various harmful conditions which are affecting them through cancer and immunotherapy drugs are helping the people out. Rising cancer therapies coupled with lesser side effects are the factors provoking the market demand. Moreover high prevalence of lifestyle diseases are sustaining the market growth. However, high cost of therapy drugs is major factor restraining the market.

Monoclonal antibodies is accounted for largest market share while Checkpoint inhibitors is estimated to be the fastest growing segment on account of its less effect to normal cells compared to ordinary therapeutics. North America commanded the largest market share followed by Europe owing to large government funding in cancer techniques and R&D. Quick drug approvals is also a major factor helping the regional growth.

Some of the key players of the Immunotherapy Drugs market include Aduro BioTech Inc, Agenus Inc, Amgen Inc., Bavarian Nordic A/S, Bellicum Pharmaceuticals Inc, Biogen Idec Inc, Bristol-Myers Squibb Company, Celgene Corporation, DenDrit Biotech USA, ELI Lilly and Company, F. Hoffmann-La Roche Ag, Galena Biopharma Inc, Genentech Inc, Glaxosmithkline Plc, Merck & Co., Inc., NewLink Genetics Corp., Novartis International Ag, Oxford BioTherapeutics Ltd., Seattle Genetics, Inc. and Spectrum Pharmaceuticals, Inc..

Drug Types Covered:
Checkpoint Inhibitors
Interferons
Interleukins
Monoclonal Antibodies
Vaccines

Applications Covered:
Blood Cancer
Breast Cancer
Cervical Cancer
Gastric Cancer
Glioblastoma
Lung Cancer
Melanoma
Prostate Cancer

Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
France
Italy
UK
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of Asia Pacific
Rest of the World
Middle East
Brazil
Argentina
South Africa
Egypt

What our report offers:
Market share assessments for the regional and country level segments
Market share analysis of the top industry players
Strategic recommendations for the new entrants
Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements


1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging markets
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Immunotherapy Drugs, By Type of Drugs
5.1 Introduction
5.2 Checkpoint Inhibitors
5.3 Interferons
5.4 Interleukins
5.5 Monoclonal Antibodies
5.6 Vaccines
6 Global Immunotherapy Drugs, By Application
6.1 Introduction
6.2 Blood Cancer
6.3 Breast Cancer
6.4 Cervical Cancer
6.5 Gastric Cancer
6.6 Glioblastoma
6.7 Lung Cancer
6.8 Melanoma
6.9 Prostate Cancer
7 Global Immunotherapy Drugs market, By Geography
7.1 North America
7.1.1 US
7.1.2 Canada
7.1.3 Mexico
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 Italy
7.2.4 UK
7.2.5 Spain
7.2.6 Rest of Europe
7.3 Asia Pacific
7.3.1 Japan
7.3.2 China
7.3.3 India
7.3.4 Australia
7.3.5 New Zealand
7.3.6 Rest of Asia Pacific
7.4 Rest of the World
7.4.1 Middle East
7.4.2 Brazil
7.4.3 Argentina
7.4.4 South Africa
7.4.5 Egypt
8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies
9 Company Profiling
9.1 Aduro BioTech Inc
9.2 Agenus Inc
9.3 Amgen Inc.
9.4 Bavarian Nordic A/S
9.5 Bellicum Pharmaceuticals Inc
9.6 Biogen Idec Inc
9.7 Bristol-Myers Squibb Company
9.8 Celgene Corporation
9.9 DenDrit Biotech USA
9.10 ELI Lilly and Company
9.11 F. Hoffmann-La Roche Ag
9.12 Galena Biopharma Inc
9.13 Genentech Inc
9.14 Glaxosmithkline Plc
9.15 Merck & Co., Inc.
9.16 NewLink Genetics Corp.
9.17 Novartis International Ag
9.18 Oxford BioTherapeutics Ltd.
9.19 Seattle Genetics, Inc.
9.20 Spectrum Pharmaceuticals, Inc.
List Of Tables
Table 1 Global Immunotherapy Drugs market, By Region (2013-2022) ($MN)
Table 2 Global Immunotherapy Drugs market, By Type of Drugs (2013-2022) ($MN)
Table 3 Global Immunotherapy Drugs market, By Checkpoint Inhibitors (2013-2022) ($MN)
Table 4 Global Immunotherapy Drugs market, By Interferons (2013-2022) ($MN)
Table 5 Global Immunotherapy Drugs market, By (2013-2022) Interleukins ($MN)
Table 6 Global Immunotherapy Drugs market, By Monoclonal Antibodies (2013-2022) ($MN)
Table 7 Global Immunotherapy Drugs market, By Vaccines (2013-2022) ($MN)
Table 8 Global Immunotherapy Drugs market, By Application (2013-2022) ($MN)
Table 9 Global Immunotherapy Drugs market, By Blood Cancer (2013-2022) ($MN)
Table 10 Global Immunotherapy Drugs market, By Breast Cancer (2013-2022) ($MN)
Table 11 Global Immunotherapy Drugs market, By Cervical Cancer (2013-2022) ($MN)
Table 12 Global Immunotherapy Drugs market, By Gastric Cancer (2013-2022) ($MN)
Table 13 Global Immunotherapy Drugs market, By Glioblastoma (2013-2022) ($MN)
Table 14 Global Immunotherapy Drugs market, By Lung Cancer (2013-2022) ($MN)
Table 15 Global Immunotherapy Drugs market, By Melanoma (2013-2022) ($MN)
Table 16 Global Immunotherapy Drugs market, By Prostate Cancer (2013-2022) ($MN)
Table 17 North America Immunotherapy Drugs market, By Country (2013-2022) ($MN)
Table 18 North America Immunotherapy Drugs market, By Type of Drugs (2013-2022) ($MN)
Table 19 North America Immunotherapy Drugs market, By Checkpoint Inhibitors (2013-2022) ($MN)
Table 20 North America Immunotherapy Drugs market, By Interferons (2013-2022) ($MN)
Table 21 North America Immunotherapy Drugs market, By (2013-2022) Interleukins ($MN)
Table 22 North America Immunotherapy Drugs market, By Monoclonal Antibodies (2013-2022) ($MN)
Table 23 North America Immunotherapy Drugs market, By Vaccines (2013-2022) ($MN)
Table 24 North America Immunotherapy Drugs market, By Application (2013-2022) ($MN)
Table 25 North America Immunotherapy Drugs market, By Blood Cancer (2013-2022) ($MN)
Table 26 North America Immunotherapy Drugs market, By Breast Cancer (2013-2022) ($MN)
Table 27 North America Immunotherapy Drugs market, By Cervical Cancer (2013-2022) ($MN)
Table 28 North America Immunotherapy Drugs market, By Gastric Cancer (2013-2022) ($MN)
Table 29 North America Immunotherapy Drugs market, By Glioblastoma (2013-2022) ($MN)
Table 30 North America Immunotherapy Drugs market, By Lung Cancer (2013-2022) ($MN)
Table 31 North America Immunotherapy Drugs market, By Melanoma (2013-2022) ($MN)
Table 32 North America Immunotherapy Drugs market, By Prostate Cancer (2013-2022) ($MN)
Table 33 Europe Immunotherapy Drugs market, By Country (2013-2022) ($MN)
Table 34 Europe Immunotherapy Drugs market, By Type of Drugs (2013-2022) ($MN)
Table 35 Europe Immunotherapy Drugs market, By Checkpoint Inhibitors (2013-2022) ($MN)
Table 36 Europe Immunotherapy Drugs market, By Interferons (2013-2022) ($MN)
Table 37 Europe Immunotherapy Drugs market, By (2013-2022) Interleukins ($MN)
Table 38 Europe Immunotherapy Drugs market, By Monoclonal Antibodies (2013-2022) ($MN)
Table 39 Europe Immunotherapy Drugs market, By Vaccines (2013-2022) ($MN)
Table 40 Europe Immunotherapy Drugs market, By Application (2013-2022) ($MN)
Table 41 Europe Immunotherapy Drugs market, By Blood Cancer (2013-2022) ($MN)
Table 42 Europe Immunotherapy Drugs market, By Breast Cancer (2013-2022) ($MN)
Table 43 Europe Immunotherapy Drugs market, By Cervical Cancer (2013-2022) ($MN)
Table 44 Europe Immunotherapy Drugs market, By Gastric Cancer (2013-2022) ($MN)
Table 45 Europe Immunotherapy Drugs market, By Glioblastoma (2013-2022) ($MN)
Table 46 Europe Immunotherapy Drugs market, By Lung Cancer (2013-2022) ($MN)
Table 47 Europe Immunotherapy Drugs market, By Melanoma (2013-2022) ($MN)
Table 48 Europe Immunotherapy Drugs market, By Prostate Cancer (2013-2022) ($MN)
Table 49 Asia Pacific Immunotherapy Drugs market, By Country (2013-2022) ($MN)
Table 50 Asia Pacific Immunotherapy Drugs market, By Type of Drugs (2013-2022) ($MN)
Table 51 Asia Pacific Immunotherapy Drugs market, By Checkpoint Inhibitors (2013-2022) ($MN)
Table 52 Asia Pacific Immunotherapy Drugs market, By Interferons (2013-2022) ($MN)
Table 53 Asia Pacific Immunotherapy Drugs market, By (2013-2022) Interleukins ($MN)
Table 54 Asia Pacific Immunotherapy Drugs market, By Monoclonal Antibodies (2013-2022) ($MN)
Table 55 Asia Pacific Immunotherapy Drugs market, By Vaccines (2013-2022) ($MN)
Table 56 Asia Pacific Immunotherapy Drugs market, By Application (2013-2022) ($MN)
Table 57 Asia Pacific Immunotherapy Drugs market, By Blood Cancer (2013-2022) ($MN)
Table 58 Asia Pacific Immunotherapy Drugs market, By Breast Cancer (2013-2022) ($MN)
Table 59 Asia Pacific Immunotherapy Drugs market, By Cervical Cancer (2013-2022) ($MN)
Table 60 Asia Pacific Immunotherapy Drugs market, By Gastric Cancer (2013-2022) ($MN)
Table 61 Asia Pacific Immunotherapy Drugs market, By Glioblastoma (2013-2022) ($MN)
Table 62 Asia Pacific Immunotherapy Drugs market, By Lung Cancer (2013-2022) ($MN)
Table 63 Asia Pacific Immunotherapy Drugs market, By Melanoma (2013-2022) ($MN)
Table 64 Asia Pacific Immunotherapy Drugs market, By Prostate Cancer (2013-2022) ($MN)
Table 65 RoW Immunotherapy Drugs market, By Country (2013-2022) ($MN)
Table 66 RoW Immunotherapy Drugs market, By Type of Drugs (2013-2022) ($MN)
Table 67 RoW Immunotherapy Drugs market, By Checkpoint Inhibitors (2013-2022) ($MN)
Table 68 RoW Immunotherapy Drugs market, By Interferons (2013-2022) ($MN)
Table 69 RoW Immunotherapy Drugs market, By (2013-2022) Interleukins ($MN)
Table 70 RoW Immunotherapy Drugs market, By Monoclonal Antibodies (2013-2022) ($MN)
Table 71 RoW Immunotherapy Drugs market, By Vaccines (2013-2022) ($MN)
Table 72 RoW Immunotherapy Drugs market, By Application (2013-2022) ($MN)
Table 73 RoW Immunotherapy Drugs market, By Blood Cancer (2013-2022) ($MN)
Table 74 RoW Immunotherapy Drugs market, By Breast Cancer (2013-2022) ($MN)
Table 75 RoW Immunotherapy Drugs market, By Cervical Cancer (2013-2022) ($MN)
Table 76 RoW Immunotherapy Drugs market, By Gastric Cancer (2013-2022) ($MN)
Table 77 RoW Immunotherapy Drugs market, By Glioblastoma (2013-2022) ($MN)
Table 78 RoW Immunotherapy Drugs market, By Lung Cancer (2013-2022) ($MN)
Table 79 RoW Immunotherapy Drugs market, By Melanoma (2013-2022) ($MN)
Table 80 RoW Immunotherapy Drugs market, By Prostate Cancer (2013-2022) ($MN)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report